Clinical Trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, double-blind, sponsor-unblinded, randomized, placebo-controlled study designed to characterize the safety, tolerability, and PK of JZP047 in healthy participants following single-ascending doses of study intervention. Additionally, the effect of food on PK following a single dose of JZP047 will be assessed through comparison of PK between the fed and fasted states.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-21
Trial Details
NCT Number NCT07377539
Lead Sponsor Jazz Pharmaceuticals
Collaborators: Jazz Pharmaceuticals Ireland Limited
Conditions Healthy Participants
Enrollment 86 participants
Start Date 2026-02-03
Primary Completion 2026-07-05 (estimated)
Study Completion 2026-07-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-20